top of page

Trodelvy Cost Without Insurance: What toExpect

11 minutes ago
7 min read

Medically reviewed by Jonathan Reed, Medical Content Reviewer Oct 26 2026


Trodelvy cost without insurance can be a major concern for people considering this treatment for advanced breast cancer. Trodelvy is a prescription cancer medicine given through intravenous infusions, and its US list price is more than $21,000 for an illustrative treatment cycle. However, the actual amount a patient pays may differ considerably because of hospital charges, individual treatment requirements, and available financial assistance. Some eligible uninsured patients may even receive the medication free through the manufacturer's assistance program. Understanding the difference between list price and the full treatment bill is essential before making financial decisions. This guide explains current US pricing, additional expenses, assistance options, and practical steps for obtaining a more accurate estimate.


Trodelvy Cost Without Insurance: What toExpect | theskymeds


What Is Trodelvy and Why Is It Expensive?

Trodelvy contains sacituzumab govitecan-hziy, a medicine used to treat certain types of locally advanced or metastatic breast cancer.


It belongs to a group called antibody-drug conjugates.


These medicines combine an antibody that recognises a target on cancer cells with a cancer-fighting drug.


Trodelvy targets a protein called Trop-2 and delivers a chemotherapy-related substance known as SN-38.


Which Patients May Receive Trodelvy?

In the United States, Trodelvy has approved uses for certain adults with:

  • Unresectable locally advanced or metastatic triple-negative breast cancer.

  • Hormone receptor-positive, HER2-negative advanced or metastatic breast cancer after specified previous treatments.


As of June 2026, US approvals also include certain first-line triple-negative breast cancer settings, with or without another cancer medicine depending on tumour characteristics.


Treatment eligibility depends on the cancer diagnosis, previous therapy, and other clinical factors.


Why Does the Medicine Have a High Price?

Trodelvy is a complex biological medicine requiring specialised manufacturing, preparation, and intravenous administration.


Its price also reflects commercial factors, which are not fully explained by manufacturing complexity alone.


Patients should distinguish the manufacturer's medicine price from what a cancer centre charges for the complete treatment.


Trodelvy Cost Without Insurance: What Is the Current List Price?

According to Gilead's published Trodelvy cost information, the US list price is:

$21,337 per treatment cycle, covering two infusions.


This figure reflects the manufacturer's wholesale acquisition cost as of June 29, 2026.


It is based on an illustrative patient weighing 72 kg (approximately 159 pounds).


Importantly, it is not a personalised quote or a guaranteed cash price.


What Does One Treatment Cycle Include?

Trodelvy is commonly administered on Days 1 and 8 of a 21-day treatment cycle.


The prescribed amount is calculated using body weight.


Because the medicine comes in 180 mg single-dose vials, the number of vials required can influence the medication cost.


The treatment team may also adjust or delay doses for medical reasons.


Understanding the US Trodelvy list price and potential additional charges without insurance.

Cost Component

Published Price or Expected Variation

What It Covers

Trodelvy medicine

$21,337 illustrative list price per cycle

Two infusions for the manufacturer's 72 kg example

Infusion administration

Varies by treatment centre

Staff, equipment, and administration services

Facility charges

Varies

Hospital or outpatient clinic services

Laboratory tests

Varies

Blood counts and other monitoring

Supportive medicines

Varies

Medicines for nausea or other treatment effects

Imaging and specialist visits

Varies

Cancer monitoring and medical reviews

The $21,337 figure is the manufacturer's medicine list-price example, not an all-inclusive treatment estimate.


Will Every Uninsured Patient Pay $21,337?

No.

The final amount may be higher or lower depending on the treating facility, billing arrangements, financial assistance, and the amount of medicine required.


Some hospitals provide reduced self-pay rates.


Others may bill separately for the drug, infusion services, laboratory tests, and professional care.


Request a written estimate rather than assuming the published list price is your final bill.


What Other Expenses Should You Expect?

Trodelvy treatment involves more than receiving the medicine.


Patients may need blood tests, supportive medicines, oncology appointments, and periodic imaging.

Additional visits may be necessary if complications occur.


Infusion and Monitoring Charges

Trodelvy is administered intravenously by trained healthcare professionals.


The FDA-approved Trodelvy prescribing information describes its infusion schedule and the need for monitoring during treatment.


Healthcare professionals observe patients for infusion-related reactions and perform regular blood-count checks.


These services can generate charges separate from the medicine itself.


Side Effect Management

Trodelvy can cause severe low white blood cell counts, called neutropenia, and serious diarrhoea.


Some patients require additional medication, hydration, treatment delays, or hospital care.


Costs associated with complications are difficult to predict in advance.


Travel and Household Expenses

Transportation, accommodation near a treatment centre, time away from work, and caregiving responsibilities can also affect the household budget.


Although these are not medication charges, they deserve consideration when estimating the overall cost of care.


Can You Get Trodelvy Free Without Insurance?

Yes, some uninsured patients in the United States may qualify for free Trodelvy through the manufacturer's Patient Assistance Program.


However, eligibility is not automatic.


The official Gilead Oncology Support financial assistance guidance explains that qualifying uninsured patients may receive Trodelvy at no cost.


How Does the Patient Assistance Program Work?

Gilead Oncology Support reviews whether patients meet the applicable assistance requirements.


The programme may assess insurance status, financial circumstances, and other eligibility information.


Your oncology team can help with the enrolment process and required medical documentation.


Gilead Oncology Support contact information:


Receiving the medication free does not necessarily mean that infusion services, tests, or other healthcare costs are covered.


Is the Trodelvy Co-Pay Card Available Without Insurance?

Generally, no.

The manufacturer's co-pay savings programme is designed for eligible patients with commercial or private insurance.


It offers assistance of up to $25,000 annually toward eligible Trodelvy medication cost-sharing, subject to programme terms.


Uninsured patients should ask about the separate Patient Assistance Program instead.


Financial assistance options for patients facing Trodelvy treatment costs.

Assistance Option

Who It May Help

Important Limitation

Gilead Patient Assistance Program

Eligible uninsured US patients

Eligibility required; medicine assistance may not cover other care

Gilead Co-Pay Program

Eligible commercially insured patients

Not intended for uninsured patients

Hospital financial assistance

Patients meeting hospital requirements

Discounts and eligibility vary

Independent charities or foundations

Patients meeting specific programme criteria

Funding and availability may change

Medicaid or other coverage programmes

People eligible under applicable rules

Coverage depends on state and programme requirements


Trodelvy's published price of $21,337 per cycle is a useful starting point, not necessarily what an uninsured patient must pay. Applying for assistance before treatment begins may substantially change the expected medication expense.

How Can You Get an Accurate Trodelvy Cost Estimate?

The most useful estimate comes from the cancer centre that will actually provide treatment.


Ask to speak with an oncology financial navigator, social worker, or billing specialist.


Questions to Ask Before Treatment

  1. What is the expected medication charge for my prescribed treatment cycle?

  2. Are infusion administration and facility fees included?

  3. What will blood tests, scans, and supportive medicines cost?

  4. Is there a reduced self-pay rate?

  5. Does the hospital offer charity care or a payment plan?

  6. Can the oncology team help apply for Gilead's assistance programme?

  7. What costs would remain if the medicine itself were supplied free?


Request an itemised written estimate where possible.


Why Might Estimates Change?

Trodelvy is weight-based, so the amount of medication required can vary.


Treatment delays, dose changes, or additional supportive care may also affect billing.


A financial estimate should therefore be reviewed when the treatment plan changes.


What If You Cannot Afford Trodelvy?

Tell your oncology team about financial concerns as early as possible.


The National Cancer Institute's advice on managing cancer costs recommends discussing expenses with hospital financial counsellors, social workers, and the treating team.


What Options Are Worth Exploring?

Ask about manufacturer assistance, hospital charity care, reduced-rate billing, and manageable payment arrangements.


It may also be appropriate to check eligibility for Medicaid or other insurance coverage.


Some nonprofit organisations help with transport, lodging, or other cancer-related expenses.


A clinical trial may occasionally be relevant, but eligibility and coverage of routine care costs must be assessed separately.


Do not delay, reduce, or discontinue prescribed cancer treatment without discussing the situation with your oncologist.


Financial difficulties should be addressed through a coordinated medical and financial plan.


What Medical Safety Concerns Should You Know?

Cost is important, but treatment decisions must also consider medical safety.


Trodelvy carries serious warnings about neutropenia and diarrhoea.


Contact your cancer care team immediately if you develop fever, chills, or other signs of infection.


Report diarrhoea promptly, especially if it is severe or accompanied by dizziness, dehydration, or difficulty drinking fluids.


Seek emergency care for severe breathing difficulty, collapse, or symptoms of a serious infusion reaction.


Treatment schedules and supportive medicines must be managed by an oncology professional.


Conclusion

Trodelvy cost without insurance can be substantial. Gilead's published US list price is $21,337 for an illustrative two-infusion cycle, but actual charges depend on the patient's treatment needs, the infusion facility, and other services. Importantly, eligible uninsured patients may qualify to receive the medication free through Gilead Oncology Support, although additional healthcare expenses may remain. Hospital financial assistance and other support programmes may also help.


If Trodelvy has been recommended, ask your oncology centre for an itemised estimate and contact Gilead Oncology Support before making payment arrangements. Discuss treatment and financial concerns together with your care team rather than changing medically recommended treatment independently.


Trodelvy 200 mg Injection(Sacituzumab govitecan-hziy) injection is a Trop-2-directed | theskymeds

Frequently Asked Questions

1. How much does Trodelvy cost without insurance?

Gilead lists Trodelvy at $21,337 per illustrative treatment cycle of two infusions, based on a 72 kg patient as of June 29, 2026. Actual uninsured bills may differ and can include additional healthcare charges.

The manufacturer's published $21,337 example covers a treatment cycle containing two infusions. The amount required depends on body weight. Infusion centres may bill medication and administration services separately.

Some eligible uninsured US patients may receive Trodelvy free through Gilead's Patient Assistance Program. Eligibility must be confirmed, and other medical expenses may remain. Contact Gilead Oncology Support for details.

No. The manufacturer's co-pay savings programme is intended for eligible commercially insured patients. People without insurance should instead ask about Gilead's Patient Assistance Program.

Not necessarily. The manufacturer's published figure describes the medicine's list price for an illustrative treatment cycle. Administration, laboratory tests, specialist visits, and other services may generate separate charges.

Start with Gilead Oncology Support at 1-844-876-3358 and your cancer centre's financial counsellor. Ask about manufacturer assistance, hospital charity care, and other programmes for which you may qualify.



Comments


bottom of page